Literature DB >> 3020386

Pathogenesis of genital herpes simplex virus infection in mice. IV. Quantitative aspects of viral latency.

A M Eis, K E Schneweis.   

Abstract

Experiments in the mouse model of herpes simplex virus (HSV) infection involving the intact genital mucous membranes as inoculation site yielded the following results. In untreated mice the extent of latency was correlated with the degree of peripheral virus replication. This correlation could not be observed when the course of infection was interrupted by chemotherapy, interferon, or passive immunization. Acyclovir had little effect on peripheral virus multiplication, but markedly reduced latent ganglionic infection. As acute ganglionic infection and virus concentration in the spinal nerves were already reduced, acyclovir is assumed to inhibit either virus penetration into the nerve endings or virus replication in the ganglia. Interferon apparently has an active role in the elimination of virus infected cells from the ganglia, as its effect was restricted to a reduced rate of latency and of lethality. Passive immunization with antiserum led to similar results as ACV-treatment. While lacking a pronounced effect on virus replication in the mucous membranes, specific antibody was found to influence both virus elimination from the ganglia, and conversion from productive to latent ganglionic infection. Immune lymphocytes proved to be the only agent capable of suppressing peripheral infection, thereby inhibiting the neural spread of the virus. These results suggest that the decrease in latency may result from modulations occurring at different stages in the course of infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020386     DOI: 10.1007/bf02126049

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

Review 1.  The host response to herpes simplex virus.

Authors:  P Wildy; P G Gell
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

2.  Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

3.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

4.  Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.

Authors:  K E Schneweis; H Forstbauer; M Olbrich; M Tag
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Acute and recurrent herpes simplex in several strains of mice.

Authors:  D A Harbour; T J Hill; W A Blyth
Journal:  J Gen Virol       Date:  1981-07       Impact factor: 3.891

6.  From the National Institutes of Allergy and Infectious Diseases. Summary of a workshop on antiviral agents for genital herpesvirus infections.

Authors:  M W Myers; L A Glasgow; G J Galasso
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

7.  Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.

Authors:  W B Davis; J A Taylor; J E Oakes
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

8.  Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell-mediated and humoral immunity.

Authors:  A K Kapoor; A A Nash; P Wildy
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

9.  Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.

Authors:  J E Oakes; H Rosemond-Hornbeak
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Restricted replication of herpes simplex virus in spinal ganglia of resistant mice is accompanied by an early infiltration of immunoglobulin G-bearing cells.

Authors:  M L Cook; J G Stevens
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more
  8 in total

1.  Immunological mechanisms giving rise to latency of herpes simplex virus in the spinal ganglia of the mouse.

Authors:  K E Schneweis; M Brado; B Ebers; A Friedrich; M Olbrich; W Schüler
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

2.  The role of free radical scavengers, inhibitors of prostaglandin synthesis, and hypomethylating agents in reactivation of latent herpes simplex virus.

Authors:  S Sienko; A M Eis-Hübinger; K E Schneweis
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.

Authors:  L A Morrison; L Zhu; L G Thebeau
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Replication of herpes simplex virus type 1 and 2 in the medulla of the adrenal gland after vaginal infection of mice.

Authors:  J Podlech; F Hengerer; M Fleck; I Walev; D Falke
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  The role of the immune system in establishment of herpes simplex virus latency--studies using CD4+ T-cell depleted mice.

Authors:  D S Schmidt; A M Eis-Hübinger; K E Schneweis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology.

Authors:  J Podlech; F Hengerer; M Fleck; K Eray
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  A caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goats.

Authors:  Mariarosaria Marinaro; Giovanni Rezza; Giuseppe Del Giudice; Valeriana Colao; Elvira Tarsitano; Michele Camero; Michele Losurdo; Canio Buonavoglia; Maria Tempesta
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

8.  Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.

Authors:  Richard A Cone; Timothy Hoen; Xixi Wong; Raed Abusuwwa; Deborah J Anderson; Thomas R Moench
Journal:  BMC Infect Dis       Date:  2006-06-01       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.